Not Yet Recruiting
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD
NCT07435129
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FSHD, Facioscapulohumeral Muscular Dystrophy, +8 more
- Locations
-
Not specified